How Much Did Galatek Raise?
Funding & Key Investors

Galatek, a Singapore-headquartered science and technology firm, has secured significant capital, with its total funding reaching $30M. The company recently announced a major strategic investment of $30M, underscoring its pivotal role in advancing AI-powered automation solutions for critical sectors like life sciences and semiconductor manufacturing. This latest financing round signals a strong validation of Galatek's innovative approach and market potential.

What is Galatek?

Galatek
SoftwareEngineering SoftwareIndustrial Machinery & Equipment

Founded in 2016, Galatek is at the forefront of developing intelligent laboratory systems and advanced semiconductor process equipment. The company's dual focus allows it to serve a diverse clientele, including pharmaceutical firms, research institutions, and global semiconductor manufacturers. In the life sciences domain, Galatek provides automated platforms for complex processes such as cell culture, high-throughput drug screening, synthetic biology, NGS sequencing, and organoid research. These offerings are augmented by its proprietary Abio software platform, an integrated AI-driven solution that seamlessly combines electronic lab notebooks (ELN), laboratory information management systems (LIMS), scientific data management systems (SDMS), and robotic automation. For the semiconductor industry, Galatek delivers cutting-edge AI-driven advanced packaging solutions, encompassing automated overlay measurement systems, deep learning-based optical inspection, and precision wafer dicing equipment. With R&D and delivery centers strategically located across Germany, the United States, Japan, Malaysia, and China, Galatek operates a global supply chain model that prioritizes localized service delivery.

How much funding has Galatek raised?

Galatek has raised a total of $30M across 1 funding round:

2025

Series A

$30M

Series A (2025): $30M, investors not publicly disclosed

What's next for Galatek?

The recent major strategic investment positions Galatek for accelerated growth and further innovation in its specialized fields. This capital infusion is expected to bolster the company's research and development efforts, potentially leading to the expansion of its AI-driven automation capabilities and the enhancement of its existing product lines. Galatek's focus on both the burgeoning life sciences sector and the essential semiconductor manufacturing industry provides a robust foundation for sustained expansion. The company's global operational footprint and localized service model are key strategic assets that will likely be leveraged to capture greater market share and solidify its position as a leader in advanced automation solutions.

See full Galatek company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Software industry

Business Intelligence (BI) SoftwareSoftwareBusiness ServicesSoftware TestingProject Management
Customer Engagement PlatformsSoftware
Mobile App DevelopmentSoftware
Human Resources SoftwareSoftware

Frequently Asked Questions Regarding Galatek Financial Insights

What are the most recent funding rounds that Galatek has completed, and what were the funding rounds?
Galatek has recently completed 1 funding rounds: Series A on Dec 18, 2025.
What is the total amount of funding Galatek has raised to date?
Galatek has raised a total of $30M in funding to date.
How many funding rounds has Galatek completed?
Galatek has completed 1 funding rounds.
How much funding did Galatek raise in its most recent funding round?
Galatek raised $30M in its most recent funding round.
Which was the largest funding round in Galatek's history?
The largest funding round in Galatek's history was $30M.
See more information about Galatek